{
    "@graph": [
        {
            "@id": "gnd:1137188782",
            "sameAs": "Firestine, Steven M."
        },
        {
            "@id": "gnd:1137189061",
            "sameAs": "Lister, Troy"
        },
        {
            "@id": "gnd:4002257-2",
            "sameAs": "Antibiotikum"
        },
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A1659292204",
            "@type": "bibo:Book",
            "P1053": "1 Online-Ressource (xv, 271 Seiten)",
            "description": "Campusweiter Zugriff (Universit\u00e4t Hannover).- Vervielf\u00e4ltigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.",
            "identifier": [
                "(isbn13)9781782629870",
                "(isbn13)9781788011495",
                "(doi)10.1039/9781782629870",
                "(ppn)1659292204",
                "(firstid)BSZ:490721672"
            ],
            "publisher": "Royal Society of Chemistry",
            "subject": [
                "Drug Discovery",
                "(classificationName=rvk)VS 8700",
                "Antibiotics ; Research ; fast ; (OCoLC)fst00810432",
                "Antibiotics",
                "Drugs",
                "Pharmacology ; bicssc",
                "(classificationName=ddc)615.329",
                "(classificationName=ddc)615.19",
                "(classificationName=loc)RM267",
                "MEDICAL / Pharmacology ; bisacsh",
                "Biochemistry ; bicssc",
                "(classificationName=linsearch:mapping)che"
            ],
            "title": "Antibiotic drug discovery : new targets and molecular entities",
            "abstract": [
                "Cover; Antibiotic Drug Discovery: New Targets and Molecular Entities; Preface; Contents; Chapter 1 -- Treatment of Clostridium difficile Infections; 1.1 Background; 1.2 CDI Symptoms and Progression; 1.3 Relapse; 1.4 Diagnosis; 1.5 Prevention Measures-General Hospital Practice and Other Prevention Methods; 1.6 Current Treatment and Antibiotics; 1.6.1 Anti-Toxins; 1.6.2 Vaccines; 1.6.3 Anti-Germinants; 1.6.4 Fecal Transplantation; 1.6.5 Probiotics; 1.7 Conclusion; References; Chapter 2 -- Targeting Purine Biosynthesis for Antibacterial Drug Design; 2.1 Introduction",
                "2.3 Progress Targeting the Enzymes of De novo Purine Nucleotide Biosynthesis2.4 Progress Targeting Enzymes in the Purine Nucleotide Conversion Pathways; 2.4.1 IMPDH Structure and Mechanism; 2.4.2 Prokaryotic and Eukaryotic IMPDHs: A Comparative Analysis of Rational Drug Design; 2.4.3 Repurposing Cryptosporidium IMPDH Inhibitors as Antibiotics; 2.5 Conclusion; Acknowledgements; References; Chapter 3 -- Inhibitors of Biofilm Production; 3.1 Introduction; 3.2 Biofilms; 3.3 Strategies for Combating Biofilms; 3.3.1 Quorum Sensing Inhibitors",
                "2.1.1 The De novo Purine Nucleotide Biosynthesis Pathway2.1.2 The Purine Conversion Pathways; 2.1.3 The Purine Salvage Pathways; 2.1.4 Availability of Purine Bases and Nucleosides; 2.1.5 The Complex Interplay Between Salvage Pathways and Precursor Availability; 2.2 The Essentiality of Enzymes of the Purine Biosynthetic Pathways; 2.2.1 Essentiality of Purine Nucleotide Biosynthesis for Growth in Rich Media; 2.2.2 Essentiality of Purine Nucleotide Biosynthesis During Infection; 2.2.3 Inhibitors May Not Have the Same Phenotypes as Gene Knockouts; 2.2.4 The Problem of Resistance",
                "3.3.2 Inhibitors of AHL Based Quorum Sensing as Biofilm Inhibitors3.3.3 Inhibitors of AIP-Based Quorum Sensing as Biofilm Inhibitors; 3.3.4 Inhibitors of AI-2 Based Quorum Sensing as Biofilm Inhibitors; 3.4 Inhibition of Bacterial Signaling Pathways; 3.4.1 Interference with c-di-GMP Signaling to Inhibit Biofilm Formation; 3.4.2 Inhibition of Indole Signaling Pathways to Prevent Biofilm Formation; 3.4.3 Inhibition of Two-Component Signal Transduction Systems (TCS) to Prevent Biofilm Formation; 3.4.4 Inhibition of Other Signaling Pathways to Prevent Biofilm Formation",
                "This book identifies and elaborates the most recent and compelling strategies for antibiotic drug discovery with a primary focus on new targets, mechanisms and molecular entities",
                "3.5 Identification of Natural Products and Analogues that Prevent Biofilm Formation3.5.1 Plant Natural Products and Analogues that Prevent Biofilm Formation; 3.5.2 Marine Natural Products and Analogues that Prevent Biofilm Formation; 3.5.3 Other Natural Products that Prevent Biofilm Formation; 3.6 Antimicrobial Peptides (AMPs) that Prevent Biofilm Formation; 3.7 Inhibition of Efflux to Prevent Biofilm Formation; 3.8 Matrix Degradation to Prevent Biofilm Formation; 3.9 Conclusions; References; Chapter 4 -- Narrow Spectrum Antibacterial Agents; 4.1 Introduction; 4.2 Natural Products"
            ],
            "contributor": [
                "gnd:1137189061",
                "gnd:1137188782"
            ],
            "dcterms:contributor": "Technische Informationsbibliothek (TIB)",
            "isPartOf": "(collectioncode)ZDB-1-RSEK",
            "issued": "2017",
            "language": "http://id.loc.gov/vocabulary/iso639-1/en",
            "license": "commercial licence",
            "medium": "rda:termList/RDACarrierType/1018",
            "dcterms:subject": {
                "@id": "gnd:4002257-2"
            },
            "tableOfContents": "http://www.gbv.de/dms/bowker/toc/9781782624240.pdf",
            "volume": "no. 58",
            "isLike": "doi:10.1039/9781782629870",
            "P30128": [
                "RSC drug discovery series",
                "Drug discovery series",
                "RSC e-book collection"
            ],
            "P60163": "Cambridge"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "sameAs": "http://www.w3.org/2002/07/owl#sameAs",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "abstract": "http://purl.org/dc/terms/abstract",
        "isLike": {
            "@id": "http://umbel.org/umbel#isLike",
            "@type": "@id"
        },
        "contributor": {
            "@id": "http://purl.org/dc/terms/contributor",
            "@type": "@id"
        },
        "publisher": "http://purl.org/dc/elements/1.1/publisher",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "P30128": "http://www.rdaregistry.info/Elements/m/#P30128",
        "volume": "http://purl.org/ontology/bibo/volume",
        "description": "http://purl.org/dc/elements/1.1/description",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "title": "http://purl.org/dc/elements/1.1/title",
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "issued": "http://purl.org/dc/terms/issued",
        "P60163": "http://www.rdaregistry.info/Elements/u/#P60163",
        "tableOfContents": "http://purl.org/dc/terms/tableOfContents",
        "license": "http://purl.org/dc/terms/license",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}